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Vibrio anguillarum causes high mortality in European sea bass (Dicentrarchus labrax)
larviculture and is a hindering factor for successful sustainable aquaculture of
this commercially valuable species. Priming of the innate immune system through
administration of immunostimulants has become an important approach to control
disease outbreaks in marine fish larviculture. This study was conducted to evaluate
immunostimulation by Escherichia coli HSP70 (DnaK) in axenic European sea bass
larvae in order to protect the larvae against vibriosis. DnaK stimulates the immune
response in crustaceans and juvenile fish against bacterial infections. The use of
axenic fish larvae allows to study immunostimulation in the absence of an interfering
microbial community. At 7 days post-hatching, larvae received a single dose of alginate
encapsulated recombinant DnaK. Two non-treated control groups in which animals
either received empty alginate microparticles (C1) or no alginante microparticles (C2 and
C3) were included in the study. Eighteen hours later, all larvae, except the ones from
group C3 (non-infected control) were challenged with V. anguillarum (105 CFU, bath
infection). Mortality was daily recorded until 120 h post infection and at 18, 24, and 36 h
post infection, larvae were sampled for expression of immune related genes. Results
showed that V. anguillarum induced an immune response in axenic sea bass larvae but
that the innate immune response was incapable to protect the larvae against deadly
septicaemic disease. In addition, we showed that administration of alginate encapsulated
DnaK to axenic European sea bass larvae at DAH7 resulted in a significant, DnaK dose
dependent, upreglation of immune sensor, regulatory and effector genes. Significant
upregulation of cxcr4, cas1 and especially of hep and dic was correlated with significant
higher survival rates in V. anguillarum infected larvae. In the future recombinant DnaK
might perhaps be used as a novel immunostimulant in sea bass larviculture.
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INTRODUCTION
The production of farmed fish has increases 12 times in the
past three decades at an average annual growth of 8%, making
making it the fastest growing food production sector (1). In
Europe, the three major species reared are Atlantic salmon
(Salmo salar), European sea bass (Dicentrarchus labrax) and
sea bream (Sparus aurata). In order to further support the
growth of output, production of fish juveniles for stocking
on growing farms has to be increased. However, the latter is
hampered by high and unpredictable mortality of fish larvae
after hatching (2). Compared to the other cultured fish species,
highly sensitive to disease outbreaks. The increased sensitivity
of sea bass is related to its strong and prolonged stress-induced
cortisol increase and increased biosynthetic capacity of interrenal
tissue involving a high turnover in the corticosteroid production
and release (3). Sea bass larvae are highly susceptible to the
opportunistic pathogen Vibrio anguillarum [reviewed in (4)].
V. anguillarum, a Gram-negative bacterium, causes a deadly
septicaemic disease (5, 6). The skin, gills and intestinal epithelium
are replication sites for Vibrio. In sea bass, V. anguillarum evades
the innate immune response by inhibiting the respiratory burst
reaction in macrophages and by downregulating the expression
of apoptotic caspases (7). In addition, many Vibrio strains have
siderophore-dependent and/or siderophore-independent iron-
acquisition mechanisms [reviewed in (8, 9)], which enables them
to use iron for growth even if iron-binding, fish proteins such as
ferritin and transferrin are present.
Strategies for preventing vibriosis outbreaks in sea bass
larviculture are urgently needed. Preventive use of antibiotics and
chemotherapeutics is, for obvious reasons, no longer allowed.
Stimulation of the innate immune system [reviewed by (10,
11)] of larvae or maternal transfer of immunity [maternal
IgM, lectin, lysozyme, C3, factor B, phosvitin, lipovitellin;
reviewed by (12–15)] is an alternative approach. Administration
of immunostimulants in larvae is particularly interesting, as
they might protect the larvae against vibriosis and at the same
time create a broad spectrum innate immune memory (11).
Thus, prophylaxis of infectious diseases in fish larviculture
currently focuses on the stimulation of the innate immune
system either by manipulating the environment for example
with elevated temperature (16, 17) or supplying the diet with
immunostimulants (18, 19).
Some of the immunostimulants, such as bacterial products
(11), and plant constituents (20–24) are considered as the
activators of endogenous heat shock proteins (HSPs). Heat shock
proteins are a family of evolutionary conserved cellular proteins
and they exist in all living organisms. Under normal physiological
conditions, these proteins are produced constitutively and play
a role in protein metabolism. However, following adverse
conditions, the level of these proteins is increased in order
to protect cells from lethal damage (12, 25). In the case of
disease outbreaks, increased levels of HSPs can activate an innate
immune response through a danger-associatedmolecular pattern
(DAMP) cascade. HSP70 is a member of HSPs family with a size
of 70KDa. The prokaryotic HSP70 is often referred to as DnaK.
Eukaryotic HSP70 and DnaK have been reported to stimulate the
immune response in brine shrimp (Artemia franciscana), Pacific
white shrimp (Litopenaeus vannamei) and Southern platyfish
(Xiphophorus maculatus) against bacterial infections (20, 26–29).
In this study, we examined the effectiveness of recombinant
Escherichia coli DnaK as an immunostimulant for fish larvae
and its potential for future oral mass application in sea bass
larviculture for protecting the animals against vibriosis. To
address this, a previously validated experimental infection model
in gnotobiotic sea bass (D. labrax) larvae was used (30).
Maintaining sea bass larvae under gnotobiotic conditions allows
full control over the host-associated microbial communities (31).
Therefore, it represents an exceptional experimental system for
carrying out immunological studies related to host-pathogen
interactions. The gnotobiotic system eliminates any possible
microbial interference during the DnaK exposure period and
hence facilitates the interpretation of the results in terms
of a cause-effect relationship (32). DnaK was administered
orally, encapsulated in alginate microparticles. The method
for preparation and characterization of alginate microparticles
for oral administration of immunostimulants to gnotobiotic
sea bass larvae at day after hatching 7, has previously
been established (33). The commercial alginate used is a
polysaccharide, extracted from brown algae (kelp). Alginate
possesses muco-adhesive properties and is considered as safe due
to its biodegradability, its low toxicity and low immunogenicity
(34). Alginate microparticles are stable in sea water and they are
successfully ingested by sea bass larvae whereafter their content
is released in the gut (33).
MATERIALS AND METHODS
Cloning, Production, and Purification of
Recombinant Bacterial HSP70 (DnaK)
Recombinant DnaK (83 kDa), with additional amino acid
residues being an N-terminal thioredoxin and C-terminal
polyhistidine (6 × His) tag, was expressed by Enative, an E. coli
strain (MG155; accession number: AIZ92815.1) over-expressing
recombinant DnaK (28, 29) was cultured at 37◦C in Luria Bertani
(LB) broth containing 50 µg ml−1 kanamycin (Sigma-Aldrich,
Diegem, Belgium). Over-expression of DnaK was induced by
adding 0.5 mg/ml−1 of arabinose (Sigma-Aldrich) to the culture
and incubation for 4 h at 37◦C. For bacterial cell disruption
and DnaK collection, cultured bacteria were transferred to
sterile vials in which sterile glass beads (0.1mm) were added.
The vials were then placed in a bead beater (Lab Services,
Breda, The Netherlands) and the cell wall of the bacteria
was mechanically disrupted by agitation (twice for 30 s). The
bacterial lysate was collected by centrifugation (2200 x g for
1min at 4◦C) and the subsequent purification of DnaK was
performed using aDynabeads R©His-Tag Isolation& Pulldown kit
(Life Technologies, Aalst, Belgium) following the manufacturer’s
protocol. The endotoxin content was determined using the Toxin
Sensor Chromogenic LAL Endotoxin Assay Kit (GenScript, New
Jersey, USA) following the manufacturer’s protocol. Purified
DnaK was stored at −80◦C. The concentration of the purified
DnaK was determined using a Quick StartTM Bradford protein
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FIGURE 1 | Arabinose-induced over-production of DnaK by the Enative E. coli
strain. Purified recombinant DnaK (83 kDa), with additional amino acid
residues being an N-terminal thioredoxin and C-terminal polyhistidine (6 × His)
tag, by SDS-PAGE gel electrophoresis and Western blotting. (A) Coomassie
staining of polyacrylamide gel loaded with purified recombinant DnaK.
Molecular weight markers (M) in kDa are on the left. (B) PVDF membrane
probed for purified recombinant DnaK using a mouse monoclonal antibody
against DnaK followed by HRP-labeled donkey anti-mouse IgG (H + L),
substrate and chromogen. Molecular weight markers (M) in kDa are on the left.
assay (Bio-Rad Laboratories, Temse, Belgium) following the
manufacturer’s protocol. Samples were analyzed by SDS-PAGE
using the procedure previously described (35). Precision Plus
ProteinTM (Bio-Rad Laboratories) was used as a pre-stained
molecular weightmarker (MWrange 10–180 kDa). Proteins were
stained with the Bio-Safe Coomassie stain (Bio-Rad Laboratories)
or electrophoretically transferred to a polyvinylidene difluoride
(PVDF) membrane (Immun-Blot R© PVDF membrane, Bio-Rad
Laboratories) using a semi-dryWestern blotting system (250mA,
1 h; Trans-Blot R© Semi-Dry, Bio-Rad Laboratories). The PVDF
membrane was blocked (PBS with 0.2% Tween-20 and 5% BSA)
for 1 h at room temperature (RT) and subsequently incubated
overnight (4◦C) with a mouse monoclonal antibody against
DnaK (8E2/2; diluted 1:5000) (Enzo Life Sciences, Antwerpen,
Belgium). The membrane was washed and thereafter incubated
with horseradish peroxidase-labeled donkey anti-mouse IgG (H
+ L) (Affinity BioReagentsTM, Colorado, USA) at a dilution of
1:2500 (1 h, RT). After washing, 0.7mM 3,3′-diaminobenzidine
(Sigma-Aldrich) and 0.01% H2O2 in 0.1M Tris-HCl (pH 7.6)
were added (10min, RT). Membranes were washed and analyzed
with Western blot imaging system ChemiDocTM MP (Bio-Rad
Laboratories) (Figure 1).
Microparticle Preparation and Antigen
Encapsulation
Recombinant E. coli DnaK was encapsulated in calcium alginate
microparticles. Preparation of DnaK loaded microparticles
(median size of 84 ± 4.7µm) for oral administration to
gnotobiotic sea bass larvae at day after hatching (DAH) 7, was
done as previously described (33). Briefly, three ml of an aqueous
sodium alginate solution prepared by using low viscosity alginate
(A2158; Sigma-Aldrich, Diegem, Belgium), was dispersed in
12ml iso-octane (Sigma-Aldrich) solution containing two
lipophilic surfactants, 0.05% (v/v) Span-80 (Fagron, Weregem,
Belgium) and 0.02% (v/v) Tween-80 (Fagron). The solution was
stirred for 3min using a magnetic stirrer. Subsequently, 1500 µg
(500 µg ml−1 sodium alginate solution) recombinant DnaK was
added to the aqueous sodium alginate solution. The emulsion
was homogenized for 2min using a Turrax homogenizer (Bodart
& Co., Antwerp, Belgium). Next, 3ml of a calcium chloride
solution (700mM; Sigma-Aldrich) was added to the mixture and
was stirred for another 2min. To further harden the formed
microparticles, 15ml of isopropyl alcohol (Fagron) was added.
The resulting microparticles were separated and collected by
centrifugation (300 x g) for 3min after which the particles
were washed three times with sterile deionized water. The
microparticles were prepared fresh before every experiment and
were used immediately. The efficiency of DnaK encapsulation
was calculated as previously described (36). Thus, 200mg (wet
weight) of microparticles contained 300 µg of antigen or 1.5 µg
antigen per mg microparticles.
Axenic Sea Bass Larvae Production
European sea bass eggs that were produced by natural spawning
and were pre-disinfected (20ml l−1 0.5% active iodine for
10min) were obtained from Écloserie Marine (Gravelines,
France). Upon arrival, the eggs were transferred to cylindro-
conical tank and were acclimatized in UV-treated sea water for
4 h. For obtaining axenic sea bass larvae, the disinfection of eggs
was performed following the protocol developed by Dierckens
et al. (37). All larvae used in this study belonged to the same full-
sibling family batch. Once disinfected, 600 eggs were incubated
in 400ml of filtered (0.45µm; Sartorius, Vilvoorde, Belgium)
autoclaved artificial sea water (Instant Ocean, United Pet Group,
Virginia, US) and in presence of gentle filtered aeration (0.1µm).
During the incubation, salinity of 36 g l−1 and temperature
of 16 ± 1◦C was maintained. To sustain axenity, solutions
containing rifampicin and ampicillin were simultaneously added
in the sea water at a final concentration of 10 mg l−1. Axenity
testing was performed by inoculating 30 of eggs as well as
1ml of culture medium (collected from individual bottles) in
9ml of sterile marine broth (Carl Roth GmbH Co., Karlsruhe,
Germany) followed by incubation at 28◦C for 96 h. Incubation
bottles that were positive for bacterial growth were excluded
from the experiment. All the handlings and procedures including
hatching, stocking, and experiments, were carried out under
laminar flow hood and in a temperature-regulated room (16 ±
1◦C) with dim light (100 lux).
DnaK Administration in Axenic Sea Bass
Larvae and Challenge With V. anguillarum
For performing the experiment, axenic larvae on DAH6 were
used. Larvae were stocked per 12 animals, in sterile screw cap
vial containing 10ml of filtered, autoclaved artificial sea water in
which 10mg l−1 rifampicin was added. The vials were placed on
a rotor (4 rpm) with an axis tangential to the axis of the vials
for providing aeration. Each group consisted out of 10 vials of 12
larvae (n= 120) (Table 1 and Figure 2).
At DAH7, larvae had a mean body weight of 0.5mg. At
this stage, the animals of groups Ahigh dose, Blow dose and C1
received a single dose of 1.0mg alginate microparticles directly
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TABLE 1 | Experimental setup.
Groups
(n = 120)
Administering MPs* at day
7 after hatching
V. anguillarum infection 18h
post administering MPs
Number of larvae sampled p.i. for
expression of immune-related genes
Daily recording of survival
from 0 until 120h p.i.
18 h 24 h 36 h
Ahigh dose Loaded MPs
a Yes 36 36 36 Yes
Blow dose Loaded MPs
b Yes 36 36 36 Yes
C1 Empty MPsc Yes 36 36 36 Yes
C2 No MPs Yes 36 36 36 Yes
C3 No MPs No 36 36 36 Yes
*MPs = microparticles.
a1.0mg MPs loaded with recombinant DnaK; representing 1.5 µg of DnaK.
b0.5mg MPs loaded with recombinant DnaK + 0.5mg empty MPs; representing 0.75 µg of DnaK.
c1.0mg empty MPs.
FIGURE 2 | Schematic illustration of the experimental design.
added into the sea water. Group Ahigh dose received 1.0mg of
loaded microparticles, representing 1.5 µg of DnaK. Group
Blow dose received 0.5mg empty microparticles and 0.5mg loaded
microparticles, representing 0.75µg of DnaK. Group C1 received
only 1mg of emptymicroparticles. A control group (C2) in which
animals received no microparticles was included in the study.
Eighteen hours after administering the microparticles, groups
Ahigh dose, Blow dose, C1 and C2 were experimentally infected
(bath infection) with the virulent V. anguillarum strain HI-610
(serovar O2a, rifampicin resistant) using an infective dose of
105 CFU. The bath infection model was previously validated
during a pathogenesis study of a V. anguillarum infection in
gnotobiotic sea bass larvae (38, 39). An extra control group (C3)
in which the animals were neither treated nor challenged was
included. Mortality in all groups was monitored in all vials by
counting the living larvae (transparent and swimming) under a
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dissecting microscope at 18, 24 and 36 h p.i.. At each of these
time points, 36 larvae (whole-body larva sampling) per group
(3 biological replicates of 12 larvae = 3 vials) were euthanized
by over-anesthetization using methylsulfonatetricaine (MS-222,
Sigma) for analyzing the expression of innate immune-related
genes. Euthanized larvae were immediately snap frozen in
liquid nitrogen and were subsequently stored at −80◦C until
analysis. The remaining 12 larvae per group were monitored
till 120 h p.i. and the mortality in each group was recorded
daily. At the end of the trial, all remaining larvae were
euthanized by over-anesthetization. The experiment was carried
out in accordance with the recommendations in the European
Union Ethical Guidelines for the care of animals used for
experimental and other scientific purposes (2010/63/EU). The
trial was approved by the UGhent Ethical Committee for Animal
Experiments (EC2014/147).
Sampling and Reverse Transcription
Real-Time PCR (RT-qPCR)
At 18, 24, and 36 h p.i., the total RNA of the larvae
was extracted following the protocol described by Reyes-
López et al. (40). Briefly, the larvae of each vial were
sacrificed by over- anesthetization using sea water containing
methylsulfonatetricaine (MS-222) (Sigma). The animals were
snap-frozen in liquid nitrogen and were stored at −80◦C for
further analysis. For immune gene expression analysis, total RNA
was extracted of triplicates of 12 pooled homogenized larvae
from each group using the Total RNA Isolation Reagent (TRI
Reagent R©; Molecular Research Center, Inc., Cincinnati, USA)
(41). The quantity and quality of the RNA was tested using
a NanoDrop 2000 spectrophotometry (NanoDrop Technologies
Inc.,). The extracted RNA was then treated with RNase-free
amplification grade DNase I (Thermo Scientific, Aalst, Belgium)
following the manufacturer’s protocol and confirmed to be DNA
free by PCR for the ribosomal protein S18 (rps18) gene. One
µg of total RNA was reverse transcribed (RevertAidTM H Minus
first-strand cDNA synthesis kit; Thermo Scientific) following the
manufacturer’s protocol. RNA and cDNA samples were stored at
−80 and−20◦C, respectively.
Selected immune genes and the primers that were used for
mRNA expression analysis are presented in Table 2. Amplified
cDNA samples were subjected to RT-qPCR using a Rotor-Gene
Q (Qiagen R©) instrument with each reaction containing 15 µl
master mix containing iQTM SYBR R© Green Supermix (Bio-
Rad Laboratories), the optimum concentration of primer pair
(Table 2) and 5 µl of diluted cDNA to a final volume of 20 µl.
The RT-qPCR reaction was performed with one cycle of 95◦C
for 3min and 40 cycles of 95◦C for 15s, 57–58◦C for 1min and
72◦C for 15 s. Each of the three biological replicates was analyzed
in duplicate. Plasmids (pGEM R©-T) that contained gene-specific
insert were used as positive controls. non-reverse transcribed
total RNA of larvae and ddH2O were used as negative controls.
The endogenous rps18 gene (housekeeping gene) was used as for
normalization and the RT-qPCR efficiencies for each gene varied
between 95 and 100%, allowing the use of the 2−11CT method
for calculation of relative gene expression (fold-changes) (45).
For the effect of Vibrio infection on the larval immune
system, C2 (no MPs and challenged with V. anguillarum) gene
expression profile was studied by calculating the immune gene
expression relative to group C3 (no MPs and no Vibrio) as
the calibrator by calculating 11CT. For studying the effect of
DnaK on immune gene expression in European sea bass larvae,
mRNA expression analysis was performed relative to C1 (fed with
MPs and challenged with V. anguillarum) as the calibrator by
calculating11CT.
Statistical Analysis
To determine significant differences between various treatments,
survival data were subjected to logistic regression analysis by
using GenStat 16 (VSN International, Hemel Hempstead, UK).
Statistical analysis of gene expression was conducted using IBM
SPSS Statistics for Windows, Version 21.0 (IBM Corp., Armonk,
NY). For comparing the sea bass relative gene expression (fold-
changes) between different treatments at each time point t-
test analysis (comparisons between C2 and C3) and one-way
ANOVA (comparison between C1, Ahigh dose and Blow dose) were
performed by setting the analyses at 95% confidence intervals
(P < 0.05).
ANOVA test was followed by a post-hoc comparisons
using Tukey HSD test and data for gene expression
was log-transformed.
RESULTS
Survival of Sea Bass Larvae
During the first 36 h p.i., the proportion of survived gnotobiotic
European sea bass larvae was statistically the same for all groups
(Figure 3). At 48 h p.i., significant (P < 0.05) mortality occurred
in all V. anguillarum infected groups, except for the group
receiving the high dose (1.5 µg) of DnaK (group Ahigh dose)
(Figure 3). In the latter group, significant mortality, as compared
to the non-infected control group C3, was only observed from
72 h p.i. onwards. Mortality in all infected groups, including
group Ahigh dose, augmented further toward the end of the
experiment (Figure 3). At the end of the experiment (120 h p.i.),
only 8% of the larvae of group C2 (no MP, infected), 7% of the
larvae of group Blow dose and 21% of the larvae of group C1
(empty MP, infected) had survived the infection, showing the
ineffectiveness of DnaK administration at a low dose of 0.75 µg.
However, at the same time point, 50% of the larvae of group
Ahigh dose were still alive and the proportion of survived animals
in group Ahigh dose was statistically higher than in all other
infected groups (Figure 3) (C1, C2, and Blow dose), but lower than
for group C3 (no MP, non-infected) which showed 73% survival.
The survival results clearly demonstrated the beneficial effect of
feeding European sea bass larvae with 1mg of microparticles
loaded with 1.5 µg DnaK (Figure 3). The administration of
empty MPs (C1) also appeared to have some positive effect on
survival (Figure 3) as at 120 h p.i., the survival rate in C1 was
significantly higher than for group C2 (noMP, infected) and even
group Blow dose. However, at 120 h p.i., a significant difference (P
< 0.01) of 41% was recorded between the survival in group C1
and group Ahigh dose. Also, at h p.i. the proportion of survived
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TABLE 2 | Primer sequences used for RT-qPCR.
Gene (protein) Function Accession no. Primer* sequence (5′-3′) Primer
concentration
(nM)
References
rps18 (RPS18) Ribosomal protein S18 gene,
house keeping gene
AM490061.1 F: AGGGTGTTGGCAGACGTTAC
R: CTTCTGCCTGTTGAGGAACC
300 (42)
tlr3 (TLR3) Toll-like receptor, pathogen
recognition receptor
AB675413.1 F:TGATCCAGCTAGTGAGACTAAGG
R: TAGAGTCTGAAGTCTGGGCAGT
150 (43)
tlr5m (TLR5M) Toll-like receptor, pathogen
recognition receptor
JF266563.1 F: GGTCATCTTCAGCGGGATTGT
R: GAAGACTGTGCATCGTCTC
150 (43)
cas1 (caspase 1) Caspase 1, protease DQ198376.1 F: TATCATGTCGCACGGGAAACT
R: TTTCTCTTCTCTCCAGCACCC
450 (43)
il1β (IL-1β) Interleukin 1 beta,
pro-inflammatory cytokine
AJ269472.1 F: ATCTGGAGGTGGTGGACAAA
R: AGGGTGCTGATGTTCAAACC
300 (42)
Tnfα (TNFα) Tumor necrosis factor alfa,
pro-inflammatory cytokine
DQ070246.1 F: TGAGAGGTGTGAGGCGTTTTC
R: GATTAGTGCTTCGGTTTGGCC
300 (43)
Il10 (IL-10) Interleukin 10,
anti-inflammatory cytokine
DQ821114.1 F: CGACCAGCTCAAGAGTGATG
R: AGAGGCTGCATGGTTTCTGT
300 (42)
Mif (MIF) Macrophage migration inhibitory
factor, pro-inflammatory cytokine
FN582353.1 F: CACTGAGGAGCTGGCGAAAG
R: CACTACCTTTGGCTGAGAGGG
150 (43)
cxcl8 (CXCL8) CXC chemokine,
chemotactic cytokine
AM490063.1 F: GTCTGAGAAGCCTGGGAGTG
R: GCAATGGGAGTTAGCAGGAA
300 (42)
cxcr4 (CXCR4) Chemokine receptor 4, receptor
for CXCL12, role in cell migration,
proliferation and differentiation
FN687464.1 F: GCAAAGCACAGGGTCTTCAAA
R: TACTGTGTTGGCATCTTTTCGG
150 (43)
ccr9 (CCR9) Chemokine receptor 9, receptor
for CCL25 and role in migration,
proliferation and apoptosis
in leukocytes
FN665390.1 F: CTGATACTACCCCTGCCCTTTC
R: TTCTCGTGTGCTGCTGTAACT
150 (43)
cc1 (CC1) CC chemokine 1,
chemotactic cytokine
AM490065.1 F: CCTAACCGTGAATGTGTCCCA
R: TCCGGCCAATGAAAACACCTA
150 (43)
hpc (hepcidin) Antimicrobial peptide,
iron regulation
DQ131605.1 F: GGAATCGTGGAAGATGCCGT
R: CAGACACCACATCCGCTCAT
500 (40)
dic (dicentracin) Antimicrobial peptide AY303949.1 F: AGTGCGCCACGCTCTTTCTTGT
R: TTGTGGATGGACTTGCCGAC
GTG
500 (44)
animals in group Ahigh dose was significantly (P < 0.01) lower
by 22%, as compared to the survival in the non-infected control
group C3.
Effect of a V. anguillarum Infection on
Immune-Related Gene Transcription
In order to examine the effect of a V. anguillarum infection
on immune-related gene expression early upon infection, we
compared the tlr3, tlr5m, cas1, il1β , tnfα, mif, il10, cc1, cxcl8,
cxcr, ccr9, hpc, and dic gene transcript levels for groups C2
(no MP, infected) and C3 (no MP, non-infected) at 18, 24, and
36 h p.i. The mean gene transcript levels ± SD for group C2
relative to group C3 are presented in Figure 4. At 18 h p.i.,
only ccr9 (3.57-fold) was significantly upregulated. In addition,
tlr3 (0.02-fold) was significantly, downregulated at this time
point. At 24 h p.i., tnfα (20.25-fold), cc1 (12.11-fold), and
cxcl8 (4.60-fold) were significantly upregulated. At, 36 h p.i.,
tlr3 (47.17-fold), tnfα (6.15-fold), and cc1 (13.73-fold) were
significantly upregulated.
Effect of the Prophylactic Use of
Recombinant E. coli DnaK on
Immune-Related Gene Transcription
Following a V. anguillarum Infection
We examined the prophylactic effect of DnaK administration
prior to a vibrio infection, by studying the survival of the larvae as
well as the expression of tlr3, tlr5m, cas1, il1β , tnfα,mif, il10, cc1,
cxcl8, cxcr, ccr9, hpc, and dic genes in live animals sampled at 18,
24, and 36 h p.i. The mean gene transcript levels± SD for groups
Ahigh dose and Blow dose relative to group C1 (empty MP, infected)
are presented in Figure 5. At 18 h p.i., cas1 (6.2-fold), tnfα (17.24-
fold) and cxcl8 (7.04-fold) were significantly upregulated in group
Ahigh dose as compared to the control group C1. By 24 h p.i.,
more genes became upregulated in group Ahigh dose as transcript
levels for cc1 (3.82-fold), cxcr4 (2.56-fold), hpc (4.27-fold), and
dic (3.37-fold) had also significantly increased as compared to
the control group C1. For group Ahigh dose, significant gene
upregulation as compared to group C1 was no longer present at
36 h p.i. except for dic (1.43-fold). Significant downregulation of
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FIGURE 3 | The proportion of surviving European sea bass larvae challenged with V. anguillarum. Animals of group C1 (1.0mg of empty MPs), C2 (no MPs), Ahigh dose
(1.0mg of DnaK loaded MPs) or Blow dose (0.5mg of empty MPs and 0.5mg of DnaK loaded MPs) were challenged with 10
5 CFU of V. anguillarum. Group C3 received
no MPs and was not infected. Survival of the animals was scored before challenge (0 h p.i.) and at several time points p.i. till the end of the trial at 120 h p.i. (A) The
proportion of survived animals (mean ± SD) is represented at each time point. (B) Statistical differences in live animals for various groups at different time points after
infection with V. anguillarum. For all groups, the proportion of live fish larvae was significantly the same before 48 h p.i. Statistical differences in the proportion of
survived animals for various treatment groups, following infection are presented from 48h p.i. till the end of the experiment at 120 h p.i. An asterisks represents a
significant difference between the respective groups [not significant (NS) (P > 0.05), significant *(P < 0.05), significant ** (P < 0.01), significant *** (P < 0.001) and
significant ****(P < 0.0001)]. Comparison between a group and itself is marked in black.
genes did not occur in group Ahigh dose, except for the mif gene,
which was slightly downregulated at 18 and 24 h p.i. as compared
to the control group C1.
For group Blow dose, at 18 h p.i., only cas1 (4.14-fold) and
cxcr4 (2.88-fold) transcript levels were significantly increased
compared to the control group C1. At that time, il1β (25-
fold), mif (2.04-fold), and il10 (25-fold) were significantly
downregulated as compared to the control group C1. At 24 h p.i.,
only two genes mRNA were significantly upregulated in group
Blow dose, being tnfα (6.24-fold) and cxcr4 (3.14-fold). Expression
of mif (0.44-fold), il10 (0.22-fold), and il1B (0.22) was, albeit
slightly, downregulated at that time. Later on, at 36 h p.i. only
cas1 (4.14-fold) and dic (1.63-fold) were significantly upregulated
as compared to the control group C1.
Regarding all genes under study, cas1, cc1, cxcl8, and cxcr4
were significantly upregulated, albeit not at the same time, in
both group Ahigh dose and group Blow dose, as compared to the
control group C1. In addition, for group Ahigh dose, significant
gene upregulation, as compared to the control group C1, was also
observed for tnfα (18 h p.i.), hpc (24 h p.i.), and dic (24 h p.i.).
DISCUSSION
Industrial production of sea bass is still hampered by low and
unpredictable survival of larvae and juvenile fish due to disease
outbreaks such as infections caused by Vibrio spp. (46, 47).
Vibriosis is a bottleneck for the expansion of sustainable sea
bass aquaculture and causes high mortality especially during the
larviculture. Vibrio spp. are actually opportunistic bacteria and
therefore, vibriosis outbreak in larviculture is the result of the
combination of various factors. For example, high larval density,
accumulation of dead larvae and the introduction of bacteria
through live food that can promote selection and growth of
opportunistic bacteria, including vibrio (48). The latter might
lead to vibrio infections and in case of sea bass larvae to vibrio
replication in the skin, gills and gastrointestinal tract resulting in
deadly septiceamic disease (49).
Stimulation of the innate immune system of sea bass larvae
could perhaps protect them against vibrio infections. Therefore,
the current study focuses on oral administration of a candidate
immunostimulant, being E. coli HSP70, also known as DnaK, to
induce a protective innate immune response in sea bass larvae
against mortality caused by V. anguillarum. For this purpose, a
previously generated experimental infection model in axenic sea
bass larvae (37) was used exposing the animals to vibrio through
the sea water (49).
Immunostimulants are commercially available for fish
farming. Seaweed-based (AQUAVAC R© ErgosanTM; MSD
Animal Health, New Jersey, USA), yeast β-glucan-based
(MacroGard R©; Biorigin, Antwerp, Belgium and Bio-Mos R©;
Alltech Inc, USA) and Saccharomyces cerevisiae beta-glucans and
mannanoligosaccharides-based (ExcelMOS R©, Global Nutritech;
VA, USA) immunostimulants have been successfully applied
in juvenile rainbow trout (O. mykiss), juvenile/adult sea bass
(D. labrax), juvenile carp (Cyprinus carpio) and seabream (S.
aurata) broodstock (50–55). In fish farms, these commercial
immunostimulants are being incorporated in the diet. The
application of other immunostimulants such as vitamins (i.e.,
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FIGURE 4 | The effect of Vibrio challenge on relative expression of TLR, cytokine, chemokine and chemokine receptor genes in gnotobiotic sea bass larvae. Animals
that were not fed with MPs were either cultured without challenge (C3) or were challenged with V. anguillarum at 105 CFU (C2). Animals were sampled at 18 (A), 24
(B), and 36 (C) h p.i. Gene expression results for C2 are presented relative to the C3 values. Bars represent the standard deviation (SD) of the mean. An asterisks (*)
represents a significant (P < 0.05) change in gene expression for C2 compared to C3.
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FIGURE 5 | The effect of treating the animals with DnaK on the relative
expression of TLR, cytokine, chemokine and chemokine receptor genes in
gnotobiotic sea bass larvae. The larvae were divided into 3 different groups
and were fed with either empty MPs (C1) or encapsulated DnaK at a high
(Continued)
FIGURE 5 | (Ahigh dose) or low dose (Blow dose) prior to infection with 10
5 CFU of
V. anguillarum. Animals were sampled at 18 (A), 24 (B), and 36 (C) h p.i. Gene
expression results for the Ahigh dose and Blow dose groups are presented as
fold-changes relative to C1. Bars represent the standard deviation (SD) of the
mean. An asterisks (*) indicates a significant difference (P < 0.05) for the high
(Ahigh dose) or low dose (Blow dose) group compared to C1.
vitamin C and E), microorganisms (i.e., probiotic bacteria),
prebiotics (Bio-Mos R©), hormones (i.e., thyroxine), biologically
active compounds (i.e., antimicrobial peptides, lectins, bovine
lactoferrin), medicinal herbs [i.e., Astragalus membranaceus
and Lonicera japonica (honeysuckle) extracts], amino acids (i.e.,
DL-arginine), poly-β-hydroxybutyrate and organic pigments
(i.e., carotenoid and astaxanthin) has also been studied in
various aquaculture species (44, 56–59). However, data from
application of immunostimulants in fish larvae are limited
[reviewed by (18, 60)]. Nevertheless, the existing data point in
the direction of considerable benefit and little detrimental effect
to the developing animal (44).
Microparticles (MPs) are delivery systems used for the
administration of immunostimulants in a controlled manner
(61). Delivery of immunostimulants in fish using different types
of microparticles has been described. Microparticles out of a
synthetic amino acid being poly(D,L-lactide-co-glycolide) or
PLGA or out of natural polymers such as calcium phosphate
particles, chitosan particles, liposomes, and alginate particles
have been used for targeting the immune system of fish (62, 63).
Inorganic materials such as carbon nanotubes have also been
used as a delivery system. However, they are not biodegradable
(64). Natural polymers are most widely used due to their
bioactivity, biocompatibility, chemical stability, low toxicity,
susceptibility to enzymatic degradation and low production
costs (65). One of the commonly used natural polymers is
alginate. Alginate MPs can be prepared by extruding a solution of
sodium alginate containing proteins as a droplet into a divalent
cross-linking solution such as a Ca2+ solution. Gelation and
cross-linking of alginate polymers is than mainly achieved by
the exchange of sodium ions from the guluronic acids of the
alginate with the divalent cations of the cross linking solution.
A characteristic “egg-box” structure is formed by the stacking
of these guluronic groups (66). By selecting the alginate type
and the formulation conditions it is possible to control the
characteristics of the alginate MPs delivering the encapsulated
immunostimulant in a controlled release manner.
In larviculture, encapsulated immunostimulants in alginate
MPs can easily be introduced into the water. This action does
not provoke stress to the fish larvae. Microparticles of the correct
size can be designed to ensure the uptake of the particles by
marine fish larvae. Formerly, we evaluated MP uptake in axenic
European sea bass at day after hatching 7 (DAH7; the mouth
opening begins between DAH4 and DAH5) using fluorescent
MPs. We observed that smaller MPs (<20µm) were taken up
passively, thus unintentionally, through the natural drinking
activity, which was actually rather low (4.1 ± 0.1 nl h−1 larva−1)
in sea bass larvae. Larger MPs (45 to 80µm) were taken up
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actively as they were more easily noticed by the larvae and
probably regarded as prey (33). Alginate MPs with a median size
of 83.19 ± 4.73µm were optimal for administration to sea bass
larvae at DAH7, as 2 h after feeding a mean of 81.9 ± 9.0% of
the larvae had ingested the MPs and by 48 h after feeding 100% of
the larvae showed an accumulation ofMPs along the midgut. The
MPs disintegrated in the hindgut releasing their content locally.
So, in the correct study, we created an alginate carrier matrix
for the recombinant DnaK for oral delivery to axenic sea bass
larvae at DAH7. The encapsulation efficiency was 19.7% which
was the same as described by Yaacob et al. (33). The carrier matrix
protected the DnaK from the external environment as it was
stable in sea water (33) and provided localized delivery to the
gastrointestinal tract of fish larvae.
In the current study, we first examined the expression of
innate immune-related genes during a V. anguillarum infection
in axenic sea bass larvae, comparing group C2 (no MP, infected)
to C3 (no MP, non-infected). The expression of sensor (tlr3,
tlr5m, cxcr4, ccr9), regulatory (il10, cas1, il1β , tnfα, mif1, cxcl8)
and effector (hpc, dic) genes was studied early upon infection as
the first time points of infection are critical for fish immunity
(67). Previously, we demonstrated the expression of all sensor
and regulatory genes under study in axenic sea bass larvae
(43). The expression of hpc and dic has been demonstrated by
others in axenic and non-axenic sea bass larvae, respectively (44,
67). Possible Vibrio (Gram-negative bacterium with a flagellum)
pathogen associated molecular patterns (PAMPs) that might
stimulate the pathogen recognition receptors (PRRs) of fish
are flagellin (TLR5), peptidoglycan (TLR1 and 2, and NOD1
and NOD2), lipoproteins (TLR1 and 2), lipo-arabinomannan
(TLR1 and 2) and glycosyl-fosfatidylinositol (TLR1 and 2).
Thus, TLR5M is expressed in European sea bass larvae (43),
but we do not know if the other PRRs for Vibrio are present
at these early live stages and if they are already expressed
on innate immune cells and/or mucosal epithelial cells in the
skin, the gills and the gut, which are the primary replication
sites for Vibrio. At present, we noticed the expression of
tlr5m (receptor for bacterial flagellin) in larvae but transcript
levels were statistically the same for all groups. We noticed
a significant upregulation for tlr3 in group C3, but we have
no explanation for this observation. Actually, only few other
immune-related genes were upregulated following infection. The
latter is in contradiction with our previous results using the
same experimental infection model, the same V. anguillarum
strain and the same infective dose (43). During the latter
study, V. anguillarum highly upregulated the expression of all
genes under study (the same gene panel as currently with the
exception of hpc and dic) except for cxcr4 and ccr9. Significant
mortality occurred also later (from 72 hp.i. onwards) than in
the current study. Perhaps, animals used in the present study,
which came from another broodstock, were less robust and/or
less immunocompetent, as at the end of the trial (120 h p.i.)
only 73 ± 0.05% of the animals in group C3 (no MP, non-
infected) were still alive, while in our former study 96.67 ±
3.33% were still alive at 120 h p.i. Indeed, we need to consider
that all the individuals in the present and former study were
full-sibling (limited genetic variability), but they originated from
another broodstock. In Atlantic salmon (Salmo salar), it has been
demonstrated that the same pathogen can differentially affect the
survival of different full-sibling groups and that this is due to
differences in their ability tomount an effective immune response
(67). Differences in survival rates have also been observed by
Dierckens et al. (37), performing two independentV anguillarum
(strain HI-610 at 105 CFU) challenge trials in axenic European
sea bass larvae.
In the current study, we showed that 1mg alginate
microparticles, containing in total 1.5 µg (group Ahigh dose)
recombinant E. coli HSP70 (DnaK) could be added to the
sea water, resulting in the uptake of microparticles and
significantly augmented transcription levels for immune-related
sensor (cxcr4), regulatory (cas1, tnfα, cc1, and cxcl8) and effector
(hpc, dic) genes. Thus, significantly elevated transcription levels
for sensor, regulatory and effector genes were correlated with
increased resistance of the larvae to a lethal infection with V.
anguillarum. Whether the augmented transcription of tnfα, cc1
and cxcl8 in group Ahigh dose was due to DnaK is not certain, as
these genes were also upregulated by the Vibrio infection itself.
However, in group Ahigh dose, significantly augmented expression
levels for tnfα and cxcl8 were observed earlier (18 h p.i.) upon
infection as compared to group C2 (no MP, infected). Group
Blow dose was not significantly protected. This might be due to
the fact that only sensor (cxcr4) and regulatory (cas1, cc1, and
cxcl8) genes were significantly upregulated and not the effector
genes hpc and dic, at least not at 18, 24, and 36 h p.i. Strangely,
the administration of empty MPs also seemed to have some
positive effect on survival following infection as at 120 h p.i., the
survival rate in group C1 was significantly higher than in group
C2 (no MP, infected). This is possibly due to the fact that animals
received no larval fish food during this trial (to ensure axenic
conditions), but alginate MPs can also be used as food, rendering
the larvae of group C1 more robust than the ones from group C2.
At 120 h p.i., the survival rate in group C1 was also significantly
higher than in group Blow dose. Here, the metabolic cost of an
albeit inefficient prophylactic strategy (too low dose of DnaK)
might be the reason for the observed difference in survival.
Both cxcr4 and cas1 were significantly upregulated by DnaK
administration, and in our study, not by Vibrio. CXCR4
is a master regulator of innate immune responses. CXCR4
signaling is important for cell migration, proliferation and
differentiation (68). Cas1 mRNA levels were upregulated, but it
was not accompanied or followed by an upregulation of il1β
mRNA levels. Cas1 upreglation could have played a role in
pyroptosis, a gasdermin (GSDM)-dependent inflammatory type
of programmed cell death (69). Different from mammals, which
have a panel of pyroptotic GSDM members (e.g., GSDMA-E),
teleosts only possess GSDME. Jiang et al. (69) found that teleost
GSDME exerted pyroptotic activity and bactericidal activities
through its N-terminal domain. GSDME is specifically and highly
efficiently cleaved by teleost caspase 1, releasing the N-terminal
domain. The N-terminal domain exhibits lipid-binding and pore
forming capacity, which, when recruited to the cell membrane,
leads to cell death and massive release of proinflammatory
cellular content. The N-terminal domain of GSDME was also
lethal to E. coli. Thus, elevated cas1 expression could have
contributed in this way to protection against V. anguillarum.
However, this needs to be examined in more detail.
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It is clear from our results that augmented expression levels
for hpc and dic contributed to the observed partial protection in
the infected groups. Recently, both hpc and dicmRNA levels and
hepcidin and dicentracin peptides have been found in European
sea bass eggs and throughout larval development (70). Also,
upregulation of hpc was shown to be directly related to reduced
mortality in European sea bass challenged with V. anguillarum
HI-610 (bath 108 CFU) at DAH5 (40). In addition, it was
shown that synthetic hepcidin of fish could induce significant
protection in sea bass challenged with V. anguillarum (71).
Meloni et al. (72) described the importance of dicentracin in
protecting juvenile European sea bass against V. anguillarum
and more recently, Franke et al. (44) suggested that poly-B-
hydroxybutyrate (PHB)-induced dic expression might play a role
in protection of European sea bass postlarvae (DAH 28–38)
against vibriosis. Similar results were obtained in axenic Nile
tilapia (Oreochromis niloticus) larvae (73).
In response to pathogens, fish cells secrete hepcidin
and/or dicentracin amongst a number of other AMPs which
possess different antimicrobial activities such as formation
of transmembrane pores, hindering synthesis of cell-wall
and inhibiting cytoplasmic membrane septum formation thus
disrupting membrane structure. In addition, they can also
deactivate enzymes and inhibit the synthesis of proteins as
well as nucleic acids [reviewed by (74)]. Hepcidin has a dual
function, it exerts antimicrobial activities but if also plays a
role in iron regulation removing iron from the bloodstream
and rendering it unavailable for bacterial growth. Hepcidin
can bind and interfere with the outer membrane of bacteria
leading to its destruction and eventual death of the bacteria.
Furthermore, hepcidin can also destroy bacteria through
interaction and hydrolysis of bacterial DNA (75). Dicentracin
belongs to the family of piscidins. Fish piscidins are stored
in granules of phagocytic granulocytes and are delivered to
pathogen-containing phagosomes upon phagocytosis to kill the
pathogens (76).
CONCLUSIONS
Our study shows that V. anguillarum induces an immune
response in axenic sea bass larvae but that the innate immune
response was incapable to protect the larvae against deadly
septicemic disease. In addition, we showed that administration
of alginate encapsulated recombinant E. coli HSP70, also known
as DnaK, to axenic European sea bass larvae at DAH7 resulted
in a significant, DnaK dose dependent, upreglation of immune
sensor, regulatory and effector genes. Significant upregulation
of cxcr4, cas1 and especially of hep and dic was correlated
with significant higher survival rates in V. anguillarum infected
larvae. In the future, recombinant DnaK might perhaps be
used as a novel immunostimulant in sea bass larviculture.
However, our study showed that there is still room for
improvement as mortality still occurred in the DnaK treated
larvae. A higher DnaK dose and/or repeated administrations
instead of a single dose could perhaps further improve this
immunostimulatory strategy.
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